Biological mechanisms of stroke prevention by physical activity in type 2 diabetes

Acta Neurologica Scandinavica

Volumn 119, Issue 4, 2009, Pages 213-223

  Agosti, V ^a   Graziano, S ^a   Artiaco, L ^a   Sorrentino, G ^a  

^a UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

Diabetes; Exercise; GLUT4; Nitric oxide; Prevention; Stroke

Indexed keywords

DISEASE PREDISPOSITION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PROPHYLAXIS; REVIEW; RISK FACTOR; STROKE;

ANIMALS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM; EXERCISE; EXERCISE THERAPY; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; HUMANS; INSULIN; LIPID METABOLISM; MUSCLE, SKELETAL; NITRIC OXIDE; RISK FACTORS; SIGNAL TRANSDUCTION; STROKE;

EID: 61849141217     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01080.x     Document Type: Review

References (122)

1. Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommitte. Circulation 2007 115 : e69 171.
2. Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006 113 : e85 151.
3. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997 14 (Suppl 5 S1 85.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 : 1047 53.
5. Jørgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 1994 25 : 1977 84.
6. Furie K, Inzucchi SE. Diabetes mellitus, insulin resistance, hyperglycemia, and stroke. Curr Neurol Neurosci Rep 2008 8 : 12 19.
7. Olsson T, Viitanen M, Asplund K, Eriksson S, Hägg E. Prognosis after stroke in diabetic patients. A controlled prospective study. Diabetologia 1990 33 : 244 9.
8. Barrett-Connor E, Khaw KT. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol 1988 128 : 116 23.
9. Megherbi SE, Milan C, Minier D et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 2003 34 : 688 94.
10. Di Carlo A, Lamassa M, Baldereschi M et al. Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project. J Neurol Sci 2006 244 : 143 50.
11. Pereira MA, Kriska AM, Joswiak ML et al. Physical inactivity and glucose intolerance in the multiethnic island of Mauritius. Med Sci Sports Exerc 1995 27 : 1626 34.
12. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin-dependent diabetes in middle aged British men. BMJ 1995 310 : 560 4.
13. Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997 20 : 537 44.
14. Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz LO. Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care 1994 17 : 1067 74.
15. LaMonte MJ, Blair SN, Church TS. Physical activity and diabetes prevention. J Appl Physiol 2005 99 : 1205 13.
16. Hamdy O, Goodyear LJ, Horton ES. Diet and exercise in type 2 diabetes mellitus. Endocrinol Metab Clin North Am 2001 30 : 883 907.
17. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in life style among subjects with impaired glucose tolerance. N Engl J Med 2001 344 : 1343 50.
18. Lindström J, Louheranta A, Mannelin M et al. The Finnish Diabetes Prevention Study (DPS): life style intervention and 3-year results on diet and physical activity. Diabetes Care 2003 26 : 3230 6.
19. Chiasera JM, Ward-Cook KM, McCune SA, Wardlaw GM. Effect of aerobic training on diabetic nephropathy in a rat model of type 2 diabetes mellitus. Ann Clin Lab Sci 2000 30 : 346 53.
20. Balducci S, Iacobellis G, Parisi L et al. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications 2006 20 : 216 23.
21. Dela F. Other adaptations to training/inactivity in type 2 diabetics and other groups with insulin resistance: emphasis on prevention of CHD 2007. Appl Physiol Nutr Metab 2007 32 : 602 6.
22. Hu FB, Stampfer MJ, Solomon C et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 2001 134 : 96 105.
23. Blonde L, Dempster J, Gallivan JM, Warren-Boulton E. Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program. J Am Acad Nurse Pract 2006 18 : 524 33.
24. Buse JB, Ginsberg HN, Bakris GL et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007 115 : 114 26.
25. Selvin E, Marinopoulos S, Berkenblit G et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004 141 : 421 31.
26. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 321 : 405 12.
27. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001 286 : 1218 27.
28. Church TS, Cheng YJ, Earnest CP et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care 2004 27 : 83 8.
29. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 2000 132 : 605 11.
30. Fox CS, Coady S, Sorlie PD et al. Trends in cardiovascular complications of diabetes. JAMA 2004 292 : 2495 9.
31. Fox CS, Coady S, Sorlie PD et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007 115 : 1544 50.
32. Kendall DM, Bergenstal RM. Comprehensive management of patients with type 2 diabetes: establishing priorities of care. Am J Manag Care 2001 7 (10 Suppl S327 43l.
33. Goldstein LB, Adams R, Alberts MJ et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006 37 : 1583 633.
34. King GL. The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes. Ann Med 1996 28 : 427 32.
35. Xu Y, He Z, King GL. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications. Curr Diabetes Rep 2005 5 : 91 7.
36. Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 2008 45 : 1 16.
37. Lyons TJ, Bailie KE, Dyer DG, Dunn JA, Baynes JW. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest 1991 87 : 1910 15.
38. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982 32 : 1239 46.
39. Parsons MW, Barber PA, Desmond PM et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002 52 : 20 8.
40. Li PA, Shuaib A, Miyashita H, He QP, Siesjö BK, Warner DS. Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke 2000 31 : 183 92.
41. Cosentino F, Eto M, De Paolis P et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 2003 107 : 1017 23.
42. +) homeostasis in diabetes mellitus. Am J Physiol Heart Circ Physiol 2001 280 : H1480 9.
43. Stegenga ME, van der Crabben SN, Levi M et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healty humans. Diabetes 2006 55 : 1807 12.
44. Nishikawa T, Edelstein D, Du XL et al. Normalizing mithochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 : 787 90.
45. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001 108 : 1341 8.
46. Du XL, Edelstein D, Rossetti L et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000 97 : 12222 6.
47. Yamagishi SI, Edelstein D, Du XL, Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 2001 50 : 1491 4.
48. Yao D, Taguchi T, Matsumura T et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem 2007 282 : 31038 45.
49. Kendall DM, Harmel AP. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am J Manag Care 2002 8 (20 Suppl S635 53.
50. Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 2005 47 : 201 10.
51. Kuboki K, Jiang ZY, Takahara N et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000 101 : 676 81.
52. Cardillo C, Nambi SS, Kilcoyne CM et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999 100 : 820 5.
53. Hopfner RL, McNeill JR, Gopalakrishnan V. Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes. Eur J Pharmacol 1999 374 : 221 7.
54. Morise T, Takeuchi Y, Kawano M, Koni I, Takeda R. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 1995 18 : 87 9.
55. Oliver FJ, de la Rubia G, Feener EP et al. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem 1991 266 : 23251 6.
56. Ferri C, Pittoni V, Piccoli A et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995 80 : 829 35.
57. Piatti PM, Monti LD, Conti M et al. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 1996 45 : 316 21.
58. Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabetes Care 2001 24 : 1476 85.
59. Trovati M, Anfossi G. Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. J Diabetes Complications 2002 16 : 35 40.
60. Pandolfi A, Cetrullo D, Polishuck R et al. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol 2001 21 : 1378 82.
61. Festa A, D'Agostino R Jr., Mykkänen L et al. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol 1999 19 : 562 8.
62. Heywood DM, Mansfield MW, Grant PJ. Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus. Thromb Haemost 1996 75 : 401 6.
63. Conlan MG, Folsom AR, Finch A et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993 70 : 380 5.
64. Kohler HP, Carter AM, Stickland MH, Grant PJ. Levels of activated FXII in survivors of myocardial infarction - association with circulating risk factors and extent of coronary artery disease. Thromb Haemost 1998 79 : 14 18.
65. Inoguchi T, Li P, Umeda F et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000 49 : 1939 45.
66. Campos H, Genest JJ Jr., Blijlevens E et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992 12 : 187 95.
67. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996 124 : 261 71.
68. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992 93 : 189 99.
69. Lund S, Holman GD, Schmitz O, Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 1995 92 : 5817 21.
70. Douen AG, Ramlal T, Rastogi S et al. Exercise induces recruitment of the 'insulin-responsive glucose transporter'. Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J Biol Chem 1990 265 : 13427 30.
71. Brozinick JT Jr., Etgen GJ Jr., Yaspelkis BB III., Kang HY, Ivy JL. Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats. Am J Physiol 1993 265 (3Pt1 E419 27.
72. Kuo CH, Browning KS, Ivy JL. Regulation of GLUT4 protein expression and glycogen storage after prolonged exercise. Acta Physiol Scand 1999 165 : 193 201.
73. MacLean PS, Zheng D, Jones JP, Olson AL, Dohm GL. Exercise-induced transcription of the muscle glucose transporter (GLUT 4) gene. Biochem Biophys Res Commun 2002 292 : 409 14.
74. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 2000 106 : 847 56.
75. Franks PW, Loos RJ. PGC-1alpha gene and physical activity in type 2 diabetes mellitus. Exerc Sport Sci Rev 2006 34 : 171 5.
76. Ueda H, Urano Y, Sakurai T et al. Enhanced expression of neuronal nitric oxide synthase in islets of exercise-trained rats. Biochem Biophys Res Commun 2003 312 : 794 800.
77. McGee SL, Sparling D, Olson AL, Hargreaves M. Exercise increases MEF2- and GEF DNA-binding activity in human skeletal muscle. FASEB J 2006 20 : 348 9.
78. King PA, Horton ED, Hirshman MF, Horton ES. Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J Clin Invest 1992 90 : 1568 75.
79. Henriksen EJ, Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 1995 44 : 267 72.
80. Ryder JW, Yang J, Galuska D et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000 49 : 647 54.
81. Björnholm M, Kawano Y, Lehtihet M, Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 1997 46 : 524 7.
82. Rogers MA, Yamamoto C, King DS, Hagberg JM, Ehsani AA, Holloszy JO. Improvement in glucose tolerance after 1 week of exercise in patients with mild NIDDM. Diabetes Care 1988 11 : 613 18.
83. Seals DR, Hagberg JM, Allen WK et al. Glucose tolerance in young and older athletes and sedentary men. J Appl Physiol 1984 56 : 1521 5.
84. Østergård T, Jessen N, Schmitz O, Mandarino LJ. The effect of exercise, training, and inactivity on insulin sensitivity in diabetics and their relatives: what is new? Appl Physiol Nutr Metab 2007 32 : 541 8.
85. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004 53 : 294 305.
86. Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 1996 270 (2Pt1 E299 304.
87. Holmes BF, Kurth-Kraczek EJ, Winder WW. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 1999 87 : 1990 5.
88. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence for 5′AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998 47 : 1369 73.
89. Zheng D, MacLean PS, Pohnert SC et al. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 2001 91 : 1073 83.
90. Musi N, Fujii N, Hirshman MF et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001 50 : 921 7.
91. Sriwijitkamol A, Coletta DK, Wajcberg E et al. Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study. Diabetes 2007 56 : 836 48.
92. ++. J Gen Physiol 1967 50 : 551 62.
93. 2+ and cPKC. Am J Physiol 1998 275 (6Pt1 C1487 97.
94. Wu H, Rothermel B, Kanatous S et al. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J 2001 20 : 6414 23.
95. Garcia-Roves PM, Jones TE, Otani K, Han DE, Holloszy JO. Calcineurin does not mediate exercise-induced increase in muscle GLUT4. Diabetes 2005 54 : 624 8.
96. Balon TW, Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 1997 82 : 359 63.
97. Fryer LG, Hajduch E, Rencurel F et al. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes 2000 49 : 1978 85.
98. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 2000 279 : E1202 6.
99. Roberts CK, Barnard RJ, Scheck SH, Balon TW. Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent. Am J Physiol 1997 273 (1Pt1 E220 5.
100. Wojtaszewski JF, Hansen BF, Gade J et al. Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 2000 49 : 325 31.
101. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001 50 : 241 7.
102. Stephens TJ, Canny BJ, Snow RJ, McConnell GK. 5′-aminoimidazole-4- carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle. Clin Exp Pharmacol Physiol 2004 31 : 419 23.
103. Kawanaka K, Nolte LA, Han DH, Hansen PA, Holloszy JO. Mechanisms underlying impaired GLUT-4 translocation in glycogen-supercompensated muscles of exercised rats. Am J Physiol Endocrinol Metab 2000 279 : E1311 8.
104. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994 93 : 2438 46.
105. Pan DA, Lillioja S, Kriketos AD et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997 46 : 983 8.
106. Bergman RN. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? Diabetologia 2000 43 : 946 52.
107. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002 51 : 7 18.
108. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 2000 49 : 2102 7.
109. Turcotte LP, Richter EA, Kiens B. Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. untrained humans. Am J Physiol 1992 262 (6Pt1 E791 9.
110. Bruce CR, Kriketos AD, Cooney GJ, Hawley JA. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 2004 47 : 23 30.
111. Kraus WE, Houmard JA, Duscha BD et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002 347 : 1483 92.
112. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ 2006 174 : 801 9.
113. Bouchard C, Deprés JP, Tremblay A. Exercise and obesity. Obesity Res 1993 1 : 133 7.
114. Cauza E, Hanusch-Enserer U, Strasser B, Kostner K, Dunky A, Haber P. The metabolic effects of long term exercise in type 2 diabetes patients. Wien Med Wochenschr 2006 156 : 515 19.
115. Chen Y, Collins HL, Di Carlo SE. Daily exercise enhances acetylcholine-induced dilation in mesenteric and hindlimb vasculature of hypertensive rats. Clin Exp Hypertens 1999 21 : 353 6.
116. Sakamoto S, Minami K, Niwa Y et al. Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous NIDDM. Diabetes 1998 47 : 82 6.
117. Minami A, Ishimura N, Harada N, Sakamoto S, Niwa Y, Nakaya Y. Exercise training improves acetylcholine-induced endothelium-dependent hyperpolarization in type 2 diabetic rats, Otsuka Long-Evans Tokushima fatty rats. Atherosclerosis 2002 162 : 85 92.
118. Maiorana A, O'Driscoll G, Cheetham C et al. The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetics. J Am Coll Cardiol 2001 38 : 860 6.
119. Wendel-Vos GC, Schuit AJ, Feskens EJ et al. Physical activity and stroke. A meta-analysis of observational data. Int J Epidemiol 2004 33 : 787 98.
120. Chrysohoou Ch, Pitsavos Ch, Kokkinos P, Panagiotakos DB, Singh SN, Stefanadis Ch. The role of physical activity in the prevention of stroke. Centr Eur J Public Health 2005 13 : 132 6.
121. Alevizos A, Lentzas J, Kokkoris S, Mariolis A, Korantzopoulos P. Physical activity and stroke risk. Int J Clin Pract 2005 59 : 922 30.
122. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 : 1615 25.